![Megan Baldwin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 2 029 $ in data 30/06/2026
Megan Baldwin was the founder of Opthea Ltd., founded in 1984, and served as Chief Innovation Officer from 2024 to 2025.
Current jobs include Deputy Chairman at AusBiotech Ltd. since 2017, Director at Anaxis Pharma Pty Ltd., Director at Gertrude Biomedical Pty Ltd., Independent Non-Executive Director at Racura Oncology Ltd. starting in 2025, and Member at the Australian Institute of Co. Directors.
Former jobs include Chief Executive Officer at Opthea Pty Ltd. from 2012 to 2015, Independent Non-Executive Director at Invex Therapeutics Ltd. from 2021 to 2024, and Member at Roche Group Pty Ltd. Education includes a doctorate from the University of Melbourne.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 05/09/2025 | 195.299 ( 0,01% ) | 2 029 $ | 30/06/2026 | |
RACURA ONCOLOGY LTD -.--% | 25/11/2025 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| RACURA ONCOLOGY LTD | Direttore/Membro del Consiglio | 01/01/2025 |
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Corporate Officer/Principal | - |
AusBiotech Ltd.
 AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology membership company | Direttore/Membro del Consiglio | 14/12/2017 |
Anaxis Pharma Pty Ltd.
 Anaxis Pharma Pty Ltd. BiotechnologyHealth Technology Provides biotechnology and healthcare services | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| CERYVYN THERAPEUTICS LIMITED | Amministratore Delegato | 27/10/2023 |
| INVEX THERAPEUTICS LTD | Direttore/Membro del Consiglio | 30/06/2024 |
Opthea Pty Ltd. | Amministratore Delegato | 01/12/2015 |
Roche Group Pty Ltd. | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 9 |
|---|---|
Opthea Ltd.
 Opthea Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for treatment retinal diseases | Health Technology |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Commercial Services |
AusBiotech Ltd.
AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology membership company | Commercial Services |
Roche Group Pty Ltd. | |
Opthea Pty Ltd. | |
Race Oncology Ltd.
 Race Oncology Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for cancer | Health Technology |
Invex Therapeutics Ltd.
 Invex Therapeutics Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company and develops therapeutics for neurological conditions | Health Technology |
Anaxis Pharma Pty Ltd.
Anaxis Pharma Pty Ltd. BiotechnologyHealth Technology Provides biotechnology and healthcare services | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
